| P2093 | author name string | Sanjay K Srivastava | |
| | Nehal Gupta | |
| P2860 | cites work | External control of Her2 expression and cancer cell growth by targeting a Ras-linked coactivator | Q24538358 |
| | HER2 testing in gastric cancer: An update | Q26746253 |
| | Development of anticancer agents targeting the Wnt/β-catenin signaling | Q26781898 |
| | HER2 expression beyond breast cancer: therapeutic implications for gynecologic malignancies | Q26822730 |
| | beta-catenin signaling and cancer | Q28139147 |
| | Oral atovaquone compared with intravenous pentamidine for Pneumocystis carinii pneumonia in patients with AIDS. Atovaquone Study Group | Q28235773 |
| | Atovaquone suspension for treatment of Pneumocystis carinii pneumonia in HIV-infected patients | Q32054812 |
| | Antiparasitic agent atovaquone | Q34107885 |
| | The basic biology of HER2. | Q34346092 |
| | Antitumor activity of phenethyl isothiocyanate in HER2-positive breast cancer models | Q34348403 |
| | The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis | Q34493341 |
| | HER2 mediated de novo production of TGFβ leads to SNAIL driven epithelial-to-mesenchymal transition and metastasis of breast cancer | Q34614133 |
| | CG0009, a novel glycogen synthase kinase 3 inhibitor, induces cell death through cyclin D1 depletion in breast cancer cells | Q34658396 |
| | Antimalarial pharmacology and therapeutics of atovaquone | Q35131253 |
| | The taxanes: toxicity and quality of life considerations in advanced ovarian cancer | Q35602181 |
| | HER2: biology, detection, and clinical implications | Q35622862 |
| | Wnt/beta-catenin signaling pathway as a novel cancer drug target | Q35971885 |
| | Apoptosis signal-regulating kinase 1-thioredoxin complex dissociation by capsaicin causes pancreatic tumor growth suppression by inducing apoptosis | Q36218790 |
| | Penfluridol: An Antipsychotic Agent Suppresses Metastatic Tumor Growth in Triple-Negative Breast Cancer by Inhibiting Integrin Signaling Axis | Q36586118 |
| | Suppression of tumor angiogenesis by metformin treatment via a mechanism linked to targeting of HER2/HIF-1α/VEGF secretion axis | Q36689047 |
| | HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target | Q37149210 |
| | The role of STAT-3 in the induction of apoptosis in pancreatic cancer cells by benzyl isothiocyanate | Q37300043 |
| | Repurposing atovaquone: targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells | Q37376205 |
| | CBP-mediated FOXO-1 acetylation inhibits pancreatic tumor growth by targeting SirT. | Q37637287 |
| | A Wnt-ow of opportunity: targeting the Wnt/beta-catenin pathway in breast cancer | Q37764882 |
| | Pharmacological modulation of beta-catenin and its applications in cancer therapy | Q38089341 |
| | Expression of HER-2 in MCF-7 breast cancer cells modulates anti-apoptotic proteins Survivin and Bcl-2 via the extracellular signal-related kinase (ERK) and phosphoinositide-3 kinase (PI3K) signalling pathways | Q38525548 |
| | Role of Forkhead Box Class O proteins in cancer progression and metastasis | Q38647185 |
| | GSK-3 inhibition overcomes chemoresistance in human breast cancer | Q38757733 |
| | Emetine inhibits migration and invasion of human non-small-cell lung cancer cells via regulation of ERK and p38 signaling pathways | Q38838603 |
| | Molecular Pathways: Revisiting Glycogen Synthase Kinase-3β as a Target for the Treatment of Cancer | Q39067484 |
| | Intraoperative imaging of metastatic lymph nodes using a fluorophore-conjugated antibody in a HER2/neu-expressing orthotopic breast cancer mouse model | Q39197540 |
| | Wnt/beta-catenin pathway: modulating anticancer immune response | Q39286193 |
| | Efficacy and pharmacokinetics of atovaquone and proguanil in children with multidrug-resistant Plasmodium falciparum malaria | Q39417710 |
| | Caspase cleavage of HER-2 releases a Bad-like cell death effector | Q39600380 |
| | Wnt/beta-catenin signaling regulates cancer stem cells in lung cancer A549 cells | Q39751974 |
| | Selective AKR1C3 Inhibitors Potentiate Chemotherapeutic Activity in Multiple Acute Myeloid Leukemia (AML) Cell Lines | Q41872280 |
| | Atovaquone/proguanil. Prophylaxis and treatment of malaria | Q41921222 |
| | Atovaquone, a broad spectrum antiparasitic drug, collapses mitochondrial membrane potential in a malarial parasite | Q41929069 |
| | Gene expression-based discovery of atovaquone as a STAT3 inhibitor and anticancer agent | Q42094834 |
| | Chemoprevention by artesunate in a preclinical model of colorectal cancer involves down regulation of β-catenin, suppression of angiogenesis, cellular proliferation and induction of apoptosis | Q47653366 |
| | Artesunate induces apoptosis via inhibition of STAT3 in THP-1 cells | Q47653964 |
| | Quinacrine induces the apoptosis of human leukemia U937 cells through FOXP3/miR-183/β-TrCP/SP1 axis-mediated BAX upregulation | Q47862808 |
| | HER2 overexpression triggers an IL-1α pro-inflammatory circuit to drive tumorigenesis and promote chemotherapy resistance | Q49571851 |
| | NES1/KLK10 promotes trastuzumab resistance via activation of PI3K/AKT signaling pathway in gastric cancer. | Q49899463 |
| | Oxidative phosphorylation as an emerging target in cancer therapy | Q50115887 |
| | Wnt signaling in cancer. | Q51518956 |
| | Atovaquone enhances doxorubicin's efficacy via inhibiting mitochondrial respiration and STAT3 in aggressive thyroid cancer. | Q52311511 |
| | Targeting mitochondrial respiration as a therapeutic strategy for cervical cancer. | Q52328028 |
| | The HER4-YAP1 axis promotes trastuzumab resistance in HER2-positive gastric cancer by inducing epithelial and mesenchymal transition. | Q52657273 |
| | Autophagy flux inhibition augments gastric cancer resistance to the anti-human epidermal growth factor receptor 2 antibody trastuzumab. | Q53701966 |
| | Quality-Adjusted Survival With nab-Paclitaxel Versus Standard Paclitaxel in Metastatic Breast Cancer: A Q-TWiST Analysis. | Q53821179 |
| | Paclitaxel in Breast Cancer. | Q54090352 |
| | The extracellular domain of Her2 in serum as a biomarker of breast cancer | Q57112204 |
| | HER2-mediated GLI2 stabilization promotes anoikis resistance and metastasis of breast cancer cells | Q58605132 |
| | Penfluridol overcomes paclitaxel resistance in metastatic breast cancer | Q64056913 |
| | Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer | Q68090336 |
| | AKR1C3 Inhibitor KV-37 Exhibits Antineoplastic Effects and Potentiates Enzalutamide in Combination Therapy in Prostate Adenocarcinoma Cells | Q89068393 |
| | Cancer cells stemness: A doorstep to targeted therapy | Q92008867 |
| P433 | issue | 10 | |
| P921 | main subject | breast neoplasm | Q23929670 |
| P304 | page(s) | 1708-1720 | |
| P577 | publication date | 2019-07-03 | |
| P1433 | published in | Molecular Cancer Therapeutics | Q2363144 |
| P1476 | title | Atovaquone: An Antiprotozoal Drug Suppresses Primary and Resistant Breast Tumor Growth by Inhibiting HER2/β-Catenin Signaling | |
| P478 | volume | 18 | |